Rare diseases
Investigational molecules
Locations
Back to Austria2 clinical trials in Weiz, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.
AustriaAustriaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on hormone receptor-positive (HR+) and HER2-negative breast cancer, investigating innovative therapeutic approaches for patients with high recurrence risk.
Research aims to improve disease-free survival rates through targeted therapeutic interventions.
Investigating the effectiveness of elacestrant compared to standard endocrine treatments for breast cancer patients, with a focus on improving long-term outcomes.
Studies evaluate novel therapeutic approaches for both women and men with hormone-sensitive breast cancer.
Evaluation of palbociclib in combination with standard endocrine therapy, exploring enhanced treatment strategies for early-stage breast cancer.
Research focuses on improving standard treatment protocols through innovative drug combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
